N@N

Market Maker Surveillance Report. LJPC, VOXX, IMGN, I, JDST, CNBX, Winning Stocks With Lowest Price Friction For Monday, Febru

February 27, 2017 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 5428 companies with "abnormal" market making, 3610 companies with positive Friction Factors and 2562 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. La Jolla Pharmaceutical Company (NASDAQ:LJPC), Audiovox Corporation (NASDAQ:VOXX), ImmunoGen, Inc. (NASDAQ:IMGN), Intelsat S.A. (NYSE:I), Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bear 3X ETF (NYSE:JDST), Cannabics Pharmaceuticals Inc. (PINK:CNBX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  LJPC    $15.220   0.77%     6,361,355    34.84%    6,190,643    33.91%    170,712      112     
  VOXX    $0.850    0.20%     183,743      50.26%    126,396      34.58%    57,347       675     
  IMGN    $0.570    0.21%     3,181,308    41.15%    3,111,062    40.25%    70,246       1,232   
  I       $1.180    0.25%     401,040      36.10%    290,743      26.17%    110,297      935     
  JDST    $4.040    0.28%     10,176,389   40.52%    9,625,631    38.33%    550,758      1,363   
  CNBX    $0.760    0.26%     2,094,135    52.07%    1,783,185    44.34%    310,950      4,091   

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows LJPC with a dollar gain Monday of $15.22000 and a Friction Factor of 112 shares. That means that it only took 112 more shares of buying than selling to move LJPC higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

La Jolla Pharmaceutical Company (NASDAQ:LJPC) - La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. It engages in developing LJPC-501, a formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension and hepatorenal syndrome; and LJPC-401, a formulation of hepcidin for the treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease, and myelodysplastic syndrome. The company is also developing LJPC-30Sa and LJPC-30Sb, which are the gentamicin derivatives for the potential treatment of serious bacterial infections and rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California..

Audiovox Corporation (NASDAQ:VOXX) - VOXX International Corporation, together with its subsidiaries, operates as a manufacturer and distributor in the automotive, premium audio, and consumer accessories industries worldwide. The company s Automotive segment designs, manufactures, distributes, and markets rear-seat entertainment devices, satellite radio products, automotive security, remote start systems, digital TV tuners, mobile antennas, mobile multimedia devices, aftermarket/OE-styled radios, car-link smartphone telematics application, collision avoidance systems, and location-based services. Its Premium Audio segment designs, manufactures, distributes, and markets home theater systems, loudspeakers, outdoor speakers, iPod/computer speakers, business music systems, cinema speakers, flat panel speakers, Bluetooth speakers, sound bars, headphones, and digital living network alliance (DLNA) compatible devices. The company s Consumer Accessories segment designs and markets remote controls; rechargeable battery packs; wireless and Bluetooth speakers; Singtrix karaoke products; 360 Fly Action cameras; EyeLock iris identification and security related products; personal sound amplifiers; and A/V connectivity, portable/home charging, reception, and digital consumer products. The company markets its products to power retailers, mass merchants, regional chain stores, specialty and Internet retailers, independent 12 volt retailers, distributors, new car dealers, vehicle manufacturers, vehicle and transportation equipment manufacturers, system integrators, communication network providers, smart grid manufacturers, the U.S. military, cinema operators, sporting goods equipment retailers, and cell phone carriers under the Audiovox brand name, as well as other brand names and licensed brands. The company was formerly known as Audiovox Corporation and changed its name to VOXX International Corporation in December 2011. VOXX International Corporation was founded in 1960 and is headquartered in Orlando, Florida..

ImmunoGen, Inc. (NASDAQ:IMGN) - ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The company s product candidates include Mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529 and coltuximab ravtansine that are in Phase II clinical trials for the treatment of non-Hodgkin lymphoma; IMGN779 that is in Phase I clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of AML. ImmunoGen, Inc. has collaborations with Amgen Inc.; Bayer HealthCare; Biotest AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; Roche; Sanofi; Merck; and Takeda, as well as research agreement with CytomX Therapeutics, Inc. The company was founded in 1981 and is headquartered in Waltham, Massachusetts..

Intelsat S.A. (NYSE:I) - .

Direxion Trust Shs Direxion Daily Junior Gold Miners Index Bear 3X ETF (NYSE:JDST) - .

Cannabics Pharmaceuticals Inc. (PINK:CNBX) - .

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net

Contributing Sources

---